Tower Research Capital LLC (Trc) Geron Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Geron Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 134,237 shares of GERN stock, worth $150,345. This represents 0.01% of its overall portfolio holdings.
Number of Shares
134,237
Previous 78,317
71.4%
Holding current value
$150,345
Previous $110,000
66.36%
% of portfolio
0.01%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding GERN
# of Institutions
288Shares Held
502MCall Options Held
643KPut Options Held
276K-
Ra Capital Management, L.P. Boston, MA60.4MShares$67.6 Million1.42% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$52.1 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT41.1MShares$46 Million1.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA34.4MShares$38.6 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$30.5 Million5.93% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $423M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...